TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
Ethnicity is a dynamic, multidimensional social construct shaped by cultural identity, language, and customs. It influences ...
Abu Dhabi has spent years building one of the Gulf’s fastest-growing stock markets through a wave of blockbuster IPOs, only to now take one of its biggest companies private. Bloomberg's Laura Gardner ...